Introduction
============

As part of the individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP) protocol, crosslinked protein--RNA complexes are immunopurified and the RNA fragments are released by protein digestion, resulting in RNAs with a covalently bound peptide at the crosslink site ( [@ref-3]; [@ref-4]). This is followed by reverse transcription, where in theory the RNA--peptide complex leads to the premature termination of cDNA synthesis and is thus indicative of a protein's binding site. However, iCLIP libraries most likely contain a mixed population of cDNAs. The position of the crosslinked peptide can cause a premature termination of cDNAs (truncated cDNAs), and computational analyses indicated that truncated cDNAs represent 80--95% of cDNAs in the analysed iCLIP libraries ( [Figure 1a](#f1){ref-type="fig"}) ( [@ref-6]). However, for the remaining cDNAs, truncation will not take place (read-through cDNAs) and thus their sequence will encompass a full RNA fragment up to the point of RNase cleavage.

In iCLIP, the start of the truncated cDNAs should be equivalent to the position of the crosslink sites. This also applies to related techniques that rely on analysis of truncated cDNAs, including among others the FAST-iCLIP, CITS-CLIP, BrdU-CLIP, irCLIP, eCLIP and miCLIP, as reviewed recently ( [@ref-4]). Using these start positions for the RNA-binding--site assignment provides high-resolution RNA-binding information ( [@ref-1]). However, understanding the characteristics of read-through cDNAs in iCLIP is essential, since their presence could erroneously shift the boundaries of predicted RNA-binding sites to positions upstream of their true binding sites.

Methods
=======

Read--through marking protocol
------------------------------

The modified iCLIP protocol is based on the previously described protocol with modifications that enable the definition of read--through cDNAs ( [@ref-2]). HEK293 cells were crosslinked with 0.15 mJ/cm ^2^ 254 nm UV light. The cell lysate was prepared and the immunoprecipitation performed as previously described ( [@ref-1]). The mouse monoclonal BB7 serum anti-PTBP1 (a gift from C. Smith, available from ATCC, catalogue number CRL-2501) was used for all PTBP1 immunoprecipitations. After the first round of washes, the samples proceeded through 3'-adapter addition, an additional phosphorylation (0.2 µl PNK, 0.4 µl cold ATP (1 mM), 0.4 µl 10x PNK buffer, 3 µl water) and a 5'-marker ligation (6 µl water, 5 µl 4X ligation buffer, 2 µl RNA ligase, 1 µl RNasin, 2 µl 5'-marker (100 µM), 4 µl PEG400). The sequence of the 5'-marker is CAGUCCGACGAUC, which corresponds to the Illumina short RNA 5'-Adapter (RA5), part \#15013205; this sequence is not complementary to the primers used for the amplification of the iCLIP cDNA library ( [@ref-2]).

Mapping and computational analysis of iCLIP data
------------------------------------------------

The scripts used for the analyses in this paper are available in a fully documented format at the GitHub repository ( <https://github.com/jernejule/non-coinciding_cDNA_starts>).

Before mapping the cDNAs, we converted the FASTQ sequences into two FASTA format groups, based on presence of the sequence of the 5'-marker, CAGUCCGACGAUC, at the start of the read. Reads containing the 5'-marker sequence were marked as 'read-through' group. The 5'-marker sequence was then removed from further analysis and processed with the same pipeline as the remaining group of reads. To map the PTBP1 data to the genome, we used the UCSC hg19/GRCh37 genome assembly, and to map the eIF4A3 data to the transcriptome, we compiled a set of representative mRNA sequences from BioMart Ensembl Genes 79, for which we used the longest mRNA sequence available for each gene. We mapped both eIF4A3 and PTBP1 with the Bowtie2 version 2.1 alignment software, allowing two mismatches, analysed as previously described ( [@ref-1]).

Unique molecular identifiers (UMIs) were used to remove cDNAs that are a product of PCR amplification ( [@ref-1]). Thus, we quantified the number of unique cDNAs for the PTBP1 (EMBL-EBi accession number, [E-MTAB-6927](https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6927/)) and the pre-existing eIF4A3 dataset (EMBL-EBi accession number, [E-MTAB-3618](https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3618/)) after collapsing cDNAs with the same UMI and the same starting position to a single cDNA.

Prior to mapping the iCLIP data, we removed the UMIs and trimmed the 3'-Solexa adapter sequence using the [FASTX-Toolkit](http://hannonlab.cshl.edu/fastx_toolkit/) 0.0.13 adapter removal software. For both the PTBP1 and the eIF4A3 iCLIP datasets, the cDNAs were mapped, and the Weblogo of sequence composition of genomic sequence around their starts was analysed as previously described ( [@ref-1]).

Results
=======

To examine the characteristics of read-through cDNAs that are present in iCLIP cDNA libraries, we introduced an additional RNA ligation reaction that adds an oligonucleotide to the 5'-end of the RNA fragments (5'-marker; [Figure 1a](#f1){ref-type="fig"}, step 3b). Subsequently, only the read-through cDNAs contain the sequence of the new 5'-marker ( [Figure 1a](#f1){ref-type="fig"}, step 8). This read-through marking protocol differs from the traditional CLIP protocol, which ligates the 5'-adapter to the RNA fragments ( [@ref-7]). In CLIP, the 5'-adapter contains a sequence that is complementary to the 5'-PCR primer, and therefore only read-through cDNAs that contain this 5'-adapter are amplified. Here, the 5'-marker is not complementary to any PCR primer and is thus not required for amplification of the cDNAs but instead becomes part of the sequenced read.

![A modified iCLIP protocol identifies 'read-through cDNAs'.\
( **a**) A schematic description of the modified iCLIP protocol. Before lysis, cells or tissues are irradiated with ultraviolet (UV) light, which creates a covalent bond between proteins and RNAs that are in direct contact (step 1). After lysis, the crosslinked RNA is fragmented by a limited concentration of RNase I, and the RNA fragments are then co-immunoprecipitated with the RBP (step 2). Ligation of a 3'-adapter (step 3a) is followed by ligation of a 5'-marker that is unique to the modified protocol (red balloon, step 3b). After SDS-PAGE purification (step 4), the crosslinked RBP is removed through proteinase K digestion and purification of RNA fragments; since the ligation reaction is not 100% efficient, only a subset of the fragments contains both the 3'-adapter and the 5'-marker (step 5). Reverse transcription is performed with a primer that includes a barcode (orange) containing both an experimental identifier and a unique molecular identifier (UMI) (step 6). The peptide that remains at the crosslink site impairs reverse transcription and commonly leads to truncation of cDNAs at the crosslink site. Therefore, two types of cDNAs are generated: truncated cDNAs (which never contain the 5'-marker) and read-through cDNAs (some of which contain the 5'-marker). In iCLIP, the cDNA library is prepared so that both truncated and read-through cDNAs are amplified (step 7). After PCR amplification and sequencing (step 8), the 5'-marker sequence is present only at the beginning of read-through cDNAs. ( **b**-- **e**) The composition of genomic nucleotides around iCLIP cDNA-starts that were generated using the modified iCLIP protocol; 3.4% of the mapped PTBP1 iCLIP cDNAs ( **b**) and 0.2% of the mapped eIF4A3 iCLIP cDNAs ( **d**) contained a 5'-marker (read-through cDNAs), while 96.6% of the mapped PTBP1 iCLIP cDNAs ( **c**) and 99.8% of the mapped eIF4A3 iCLIP cDNAs ( **e**) lacked the 5'-marker sequence.](wellcomeopenres-3-15965-g0000){#f1}

Using this modified iCLIP protocol, we produced datasets for PTBP1 and eIF4A3 ( [Supplementary Figure 1](#SF1){ref-type="other"}). In the PTBP1 iCLIP dataset, 3.4% of the resulting reads contained the 5'-marker at their start site, while this was only the case for 0.2% of the reads for eIF4A3 ( [Figure 1b, d](#f1){ref-type="fig"}). For the 5'-marker-containing reads, we can be confident that they are a product of read-through reverse transcription. The nucleotide composition at the start sites of these read-through cDNAs is strikingly different from the remaining cDNAs ( [Figure 1c, e](#f1){ref-type="fig"}). The read-through cDNAs most often contain adenosine as their first nucleotide ( [Figure 1c, e](#f1){ref-type="fig"}, at position 1), while the remaining cDNAs show an enrichment of thymidines ( [Figure 1b, d](#f1){ref-type="fig"}, at position 1). Since the efficiency of the 5'-marker ligation is unknown, some read-through cDNAs are likely to be present in the remaining pool of cDNAs. However, the strikingly different nucleotide composition at the starts of the remaining cDNAs indicates that truncated cDNAs strongly predominate this pool.

Given that the start sites of read-through cDNAs mark the position of RNase I cleavage, it is likely that the enrichment of adenosines at this position reflects the sequence preference of RNase I, which resembles the one seen for RNase cleavage sites at the ends of cDNAs ( [@ref-1]). By contrast, the uridine preference at the start sites of the remaining cDNAs might reflect the preference of UV-C crosslinking at uridines, as well as the binding preference of the studied RNA-binding proteins, especially PTBP1, which is known to bind U-rich motifs ( [@ref-1]; [@ref-6]).

Conclusion
==========

In conclusion, we established an iCLIP read-through marking approach, which ligates an additional 5'-marker to the purified RNA fragments, to examine the sequence characteristics at the start sites of read-through cDNAs as part of the iCLIP protocol. By comparing the sequence composition at the start sites of read-through cDNAs and the remaining cDNAs of CLIP libraries of selected proteins, one can more confidently define RNA-binding sites by excluding cDNAs with read-through bias at their start sites. The approach can be applied to any other method that relies on analysis of cDNAs that truncate at specific features within.

Data availability
=================

The PTBP1 iCLIP newly generated for this manuscript, is available from ArrayExpress, accession number E-MTAB-6927: <http://identifiers.org/arrayexpress/E-MTAB-6927>.

The eIF4A3 dataset produced by the read-through marking method, but published for the purpose of other analyses ( [@ref-1]), is available from ArrayExpress, accession number E-MTAB-3618: <http://identifiers.org/arrayexpress/E-MTAB-3618>.

Software availability
=====================

**Source code available from:** <https://github.com/jernejule/non-coinciding_cDNA_starts>.

**License:** [Creative Commons Attribution 4.0](https://creativecommons.org/licenses/by/4.0/).

**Archived code at time of publication:** [https://doi.org/10.5281/zenodo.213267](http://dx.doi.org/10.5281/zenodo.213267) ( [@ref-5]).

The authors thank all members of the Ule laboratory for their assistance and discussion, and Professor Chris Smith for sharing the PTBP1 antiserum.

Supplementary material {#SM1}
======================

**Supplementary Figure 1. Quality control of the PTBP1 iCLIP experiment.** (a) Table summarising the number of cDNAs in all experiments used in this study. (b) Native acrylamide gel showing PTBP1 iCLIP PCR products that were amplified from medium (M) and high (H) cDNA size ranges. During cDNA library preparation for the modified PTBP1 iCLIP to detect 'read-through cDNAs', two size ranges of cDNAs were isolated from the denaturing acrylamide gel according to the recommended protocol, yielding cDNAs of approximately 90-190 nt. Since primer sequences add 52 nt to the cDNA size, sequences complementary to the iCLIP RNAs were approximately 40-140 nt. After amplification, 170-270 nt PCR products were obtained, including 128 nt of Illumina primer and iCLIP barcodes, corresponding to an approximate size range of mappable sequenced cDNAs of 40-140 nt (not shown).

Click here for additional data file.

10.21956/wellcomeopenres.15965.r33400

Referee response for version 1

Kudla

Grzegorz

1

Referee

MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK

**Competing interests:**No competing interests were disclosed.

25

7

2018

Version 1

In this report, Huppertz *et al.*aim to characterize the 5\' ends of reads in iCLIP experiments. This is useful because 5\' ends of reads are commonly interpreted as nucleotide-resolution protein-RNA crosslinking sites in iCLIP and derived methods. The authors introduce an additional 5\' marker ligation step in the experimental protocol that allows them to distinguish truncated reads from nontruncated reads based on a single sequencing dataset.

As the authors and the other reviewers pointed out, the method only identifies a subset of nontruncated reads, because of the limited efficiency of the 5\' marker ligation step. Thus, the results don\'t answer the question what proportion of reads are truncated - but they show that the sequence around the 5\' ends differs between truncated and nontruncated reads. This finding can potentially help filter out nontruncated reads based on their 5\' sequence signature, to increase the specificity of crosslinking site identification.

Minor comments:

1\. In principle, similar conclusions could have been reached by analysing the 5\' ends of reads produced by HITS-CLIP and other methods that include a 5\' linker ligation step. It would be interesting to compare the results of this experiment with existing HITS-CLIP data.

2\. Does the sequence signature around the 5\' end of nontruncated reads contain enough information to identify putative nontruncated reads even in the absence of 5\' marker ligation?

3\. I had been under the impression that iCLIP, by definition, includes a cDNA circularization step. From the methods and Figure 1, it is not clear whether the present protocol includes cDNA circularization. Figure 1 instead mentions a \"ligation od adapter to the start of cDNAs\". This would need to be clarified.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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This research report by Huppertz *et al.* provides a subtle but important innovation on the iCLIP protocol, which is a workhorse for labs interested in post-transcriptional regulation of gene expression by RNA binding proteins. iCLIP exploits the tendency of reverse transcriptase to terminate cDNA synthesis at residual peptide-RNA adducts. In these cases, the 3' end of the cDNA can be interpreted as a single nucleotide resolution read out of protein-RNA interactions. However, the initial CLIP and HITS-CLIP papers, which required a 5'linker for library amplification, established that some fraction of reverse transcription events are able to read through the crosslinking site. It is possible that the read through rates, if substantial, could complicate the interpretation of iCLIP data.

The authors address the problem of crosslinking site read through by ligating an RNA oligo to the 5'end of RNA fragments isolated by CLIP. These "marked" RNAs are processed via the standard iCLIP pipeline involving cDNA synthesis and circularization. Because the RNA marker is not required for amplification of the library, any reads containing this sequence must arise from read through. Using antibodies for two different RBPs, the authors demonstrate sequences at RT stop sites  versus read through sites are distinct. They also determine that a vast majority (\>97%) of reads correspond to truncated cDNAs.

The authors also identify an important caveat to their work- the quantification of read through cDNAs depends on the ligation efficiency of the 5'RNA oligo. In other words, it is possible that the truncated cDNAs are contaminated with unligated readthrough products. One possible improvement could be to perform an affinity selection of the ligated RNA products, using the 5' oligo as a handle, prior to cDNA synthesis. In this case, all of the RNA molecules would contain a marker. Any reads lacking the marker sequences could only arise from truncation. We also suggest the authors highlight the extent to which their truncation percentages could vary with ligation efficiency.

In summary, this is a technically sound experiment with literal interpretations of the data. The authors include sufficient experimental detail to reproduce the study.

Minor point:

In the results section, when describing the nucleotide composition at the first position of the read through and truncated (enrichment of A vs T, respectively), the authors identify the wrong panels. Figure 1b,d correspond to read through and c,e correspond to the truncated cDNA:

We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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Huppert and Haberman et al. presenta revised version of the widely used iCLIP protocol called "read-through marking" that is able to differentiate read-through cDNAs from the truncated ones that result from the stoppage that occurs when the reverse transcriptase encounters the covalent adduct of RBP-RNA complex at the site of UV-crosslinking site during reverse transcription in the process of making the cDNA library. This method involves the ligation of a 5-end oligonucleotide to the RNA fragments and thus distinctively marks the cDNAs that experience read-through during reverse transcription. Overall, this method is a valuable addition to the CLIP technology and will contribute to increasing the resolution of RBP binding site detection by workers in the field. Since the invention of the original HITS-CLIP and iCLIP methods, that offer detection of the exact RBP binding site and RNA-protein crosslinking site in the target RNAs at single nucleotide resolution, multiple variations of the technology have been developed, such as fast-iCLIP, irCLIP and eCLIP. However, the majority of coordinated computational analysis tools and mapping pipelines for these technologies do not utilize the abundant information provided by these technologies that give the precise location of RBP-RNA binding. This is largely due to the fact that a (variable, but probably significant) portion of the resulting cDNAs are read-through events and do not record the exact crosslinking site of RBPs to the RNA target. As a result, computational analyses suffer from noise introduced by the read-through events that are almost impossible to differentiate from the actual truncated cDNAs. Huppert and Haberman et al., on the other hand, provide an avenue to solve this problem using a straightforward experimental measurement from the technology itself and the data presented in the manuscript strongly support the validity of their new method. We believe the field will benefit greatly from this method and analytical tool, especially in providing increased precision  and detection of RBP binding sites.

We only have minor comments about the manuscript:

  Can the authors specify further about the cDNA start site identification pipeline?Is any peak calling involved? Or are the results presented in Figures 1b-e coming from analyzing the raw cDNA start sites from all cDNA fragments?   Can the authors comment on situations when the reverse transcriptase does not truncate exactly at the crosslinking site, but instead truncates after the crosslinking site, but before reaching the 5'-end of the RNA fragment, in which case this modified analysis software will not be able to catch these events?

We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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Here the authors describe an approach to quantify the degree of reverse transcriptase read-through during iCLIP cDNA library preparation. By ligating a specific oligonucleotide to the 5' ends of cross-linked RNAs, they can roughly quantify the degree of read-through and determine whether the sequence characteristics of the read-through fragments are similar to the truncated cDNAs. The approach used is clever and the paper is of a good quality. I do have a few suggestions that might improve the paper:

In the Methods section the authors mention what volume of PNK enzyme is used for the RNA ligation reactions but they do not specify units. I assume they are using NEB PNK (?) but this comes in various concentrations. I would appreciate it if the authors could also provide the number of units of enzymes in the materials and methods.

One potential issue with the method is that it is not possible (or not easy) to determine whether all 5' ends of the cross-linked RNAs have actually been ligated to their adapter. I agree with the authors that the sequence analysis strongly indicate that the ligation reaction went to completion. Have the authors done any optimization steps for the ligation reaction? It might be worth mentioning that this step may need to be optimized for each protein as the amount of RNA cross-linked to a protein can vary quite significantly.

T4 PNK ligase also introduced sequence representation biases as the enzyme seems to have a preference for certain nucleotide combinations. Did the authors have test how well their adaptor ligates to RNAs with different nucleotides at 5' ends. Most groups now routinely add random nucleotides to adapter sequences to minimize such bias (you can never completely remove it). Have the authors considered doing this? Perhaps the authors could comment on this in the manuscript.

The authors have specifically looked at the 5' ends of the read-through fragments for motif analysis. These results suggest that most of the RNA sequences in read-through fragments have A's at the 5' end, which is to be expected as the RNAs were fragmented with RNAse I. I am wondering though if it would not be also interesting to look at mutations within these read-through fragments to assess whether (a) all read-through fragments have mutations, (b) whether these primarily are deletions or substitutions and whether they cluster together. I would also be interested to see if the motifs found at or near deletions/substitutions are similar to the ones identified in the truncated cDNAs. Essentially, these analyses could answer a long-standing question about how reliably mutations are for pin-pointing the UV cross-linking site. The reason for asking this is that we sometimes observe deletions in U-rich regions and it is not always evident whether these deletions are the result of over cross-linking the cells (RNA damage) or whether these are actual UV-cross-linking sites.

Because the read-through fragments may have multiple mutations, they may not map accurately to the reference sequence. Can the authors comment on how many of the read-through reads did not or poorly align to the reference sequence?
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We thank the reviewer for the excellent suggestions, and we will provide a complete response along with the revised manuscript once we receive further reviews. For now, I would just like to clarify that this method doesn\'t work under the assumption that 5' ends have been efficiently ligated to their adapter. In fact, more likely the opposite is true, since the 5\' ends of CLIP RNAs can often be buried in the protein binding pocket, and can form RNA structures that make them inaccessible to PNK phosphorylation and ligation. Thus, we assume that the 5\' ligation efficiency is probably below 50%. It would be difficult to increase it much further due to the variable accessibility of RNA fragments.

Importantly, high ligation efficiency is not needed for the analyses used in the manuscript, since we focus primarily on those reads that have the adapter - and here we can be confident that the ligation worked, so these certainly are readthrough cDNAs. The purpose of our method is to identify the sequence characteristics of the readthrough RNAs within a standard iCLIP experiment, which maximises the recovery of RNA fragments by amplyfying them regardless of whether 5\' marker has been ligated or not.

A more thorough response will follow later.
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